Monday, January 03, 2022 12:45:04 PM
Don't let the price action fool you, play wisely of course but if they do get the nod from the FDA, there'll be plenty left in the dust.
https://ih.advfn.com/p.php?pid=nmona&article=86915286
imo
Also,, note the low volume manipulation.
https://ih.advfn.com/p.php?pid=nmona&article=86915286
imo
Also,, note the low volume manipulation.
Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?
"We hope not." Richard Dennis
Recent LXRX News
- Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference • GlobeNewswire Inc. • 05/12/2026 12:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/09/2026 01:42:51 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:31:57 AM
- Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates • GlobeNewswire Inc. • 05/07/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:01:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:59:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:32:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:20:08 PM
- Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital • GlobeNewswire Inc. • 05/04/2026 08:05:00 PM
- Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 • GlobeNewswire Inc. • 04/30/2026 12:00:00 PM
- Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting • GlobeNewswire Inc. • 04/17/2026 12:00:00 PM
- Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/24/2026 12:00:00 PM
- Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851 • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/16/2026 08:05:18 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/16/2026 08:04:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/16/2026 08:03:08 PM
- Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes • GlobeNewswire Inc. • 03/11/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:50:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 12:01:32 PM
- Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates • GlobeNewswire Inc. • 03/05/2026 11:59:00 AM
- Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences • GlobeNewswire Inc. • 03/03/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 12:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 12:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 12:19:33 PM
